Flunarizine (10 mg/day for 60 days) was given to eight postmenopausal women with common migraine. Plasma LH pulsatility fluctuation, peripheral concentrations of prolactin (PRL), cortisol, β-endorphin (β-EP), β-lipotropin (β-LPH) and Pain Total Index (PTI) were evaluated before and after treatment. PTI was significantly reduced by flunarizine, which did not affect β-LPH, β-EP and cortisol plasma levels. On the contrary, both PRL values and amplitude, and length of LH pulses had increased at the end of treatment. Flunarizine reduced head pain in postmenopausal women. However, the enhancement of both PRL and LH release indicates that this calcium antagonist might interfere with the dopaminergic tonus.
Get full access to this article
View all access options for this article.
References
1.
AmeryWK. Brain hypoxia: the turning-point in the genesis of the migraine attack?. Cephalalgia1982; 2:83–109.
2.
BarberinoADe MarinisL. Calcium antagonists and hormone release. II. Effects of verapamil on basal, gonadotropin-releasing hormone and thyrotropin-releasing hormone induced pituitary hormone release in normal subjects. J Clin Endocrinol Metab1980;51:749–53.
3.
D'ArmientoAPontecorviABigiFDe CristofaroAMRedaGGrecoV. Lack of inhibition of anterior pituitary hormone release during chronic treatment with calcium antagonists. Clin Endocrinol1984;21:233–7.
4.
StruthersADMillarJABeastallGHMcIntoshWBReidJL. Calcium antagonists and hormone release: effect of nifedipine on luteinizing hormone releasing hormone and thyrotropin releasing hormone induced pituitary hormone release. J Clin Endocrinol Metab1983;56:401.
5.
FacchinettiFGenazzaniAR. Simultaneous RIA of human β-endorphin and β-lipotropin in plasma extracts. Acta Endocrinol [Suppl]1979;225:378.
6.
MerrittETomlinsonSBrownBL. Flunarizine, a calcium influx blocker inhibits TRH but not potassium-stimulated prolactin secretion. Acta Endocrinol1984;107:31–5.
